Company
Headquarters: Guangzhou, China
Employees: 1
CEO: Mr. Roman Kopinski
$3,388
USD as of July 1, 2023
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $797.77 B |
| Visa | $530.20 B |
| JPMorgan | $495.55 B |
| Mastercard | $392.71 B |
| Bank of America | $267.48 B |
Excellerant, Inc., a development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals. The company intends to offer consulting services in the field of traditional and alternative medicine, and medical technologies; for customers to choose a clinic for treatment, as well as arrange the itinerary by building a route, which includes clinics, hospitals, and other medical institutions; and providing guide services to potential clients. Further, it provides information related to transportation and medical institutions. The company was incorporated in 2019 and is based in Brussels, Belgium. Excellerant, Inc. is a subsidiary of Swamson Capital AG.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Excellerant, Inc. has the following listings and related stock indices.
Stock: OTC: EXCL wb_incandescent